Registration Now Open
17th Annual Meeting of the
Oligonucleotide Therapeutics Society
September 26-29, 2021
The Society has made the difficult but necessary decision to host the 2021 Annual Meeting in a virtual only format due to uncertainty surrounding COVID-19 and the ability to travel internationally this year.
We look forward to providing you with an engaging online experience.
Visit our meeting website at www.2021oligomeeting.com for all the event details!
Call For Abstracts & Awards
The deadline for submissions this year has passed.
Registration Grants for Patient Advocacy Groups & Developing Country Scientists
Grant funding is available for a limited number of registrants from patient advocacy groups and researchers/scientists from developing countries. To apply for a grant please contact us at firstname.lastname@example.org with the flowing information:
Full Name / title / organization/ project or position / brief description of your desire to attend
Daniel O’Reilly, PhD, RNA Therapeutics Institute, UMass Medical School
Ronald Buijsen, PhD, Leiden University Medical Center
Joseph Ochaba, PhD, Ionis Pharmaceuticals
Erin M. McConnell, PhD, University of Ottawa
Annemieke Aartsma-Rus, PhD, Leiden University Medical Center
Leonora Abdullahu, McGill University
Shalini Anderson, PhD, AstraZeneca
Annabelle Biscans, PhD, AstraZeneca
David Corey, PhD, UT Southwestern
Masad J. Damha, PhD, FCIC, McGill University
Keith Gagnon, PhD, Southern Illinois University
Bruno Godinho, PhD, Atalanta Therapeutics
Holly Kordasiewicz, PhD, Ionis Pharmaceuticals
Aurélie Lacroix, PhD, Sixfold Biosciences
Marc Lemaitre, PhD, ML_Consult
Martin Maier, PhD, Alnylam Pharmaceuticals
John Maraganore, PhD, Alnylam Pharmaceuticals
Mano Manoharan, PhD, Alnylam Pharmaceuticals
Jimmy Weterings, PhD, AstraZeneca
Tim Yu, PhD, Boston Children’s Hospital, Harvard University